• Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • Methadone and Metabolites, Confirmation, Urine
  • Apolipoprotein E (Apo E) Genotyping
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • von Willebrand Factor Activity (Ristocetin Cofactor)
  • Phenytoin, Free, Serum
  • Avantect Pancreatic Cancer Test
  • Homovanillic Acid (HVA), 24 Hour, Urine
  • Zolpidem, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MEK1 Mutation Analysis, Melanoma
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MEK1 Mutation Analysis, Melanoma
Medical Test

Turnaround Time
Access to MEK1 Mutation Analysis, Melanoma is restricted.